Titre : Flavonols

Flavonols : Questions médicales fréquentes

Termes MeSH sélectionnés :

Concept Formation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Flavonols : Questions médicales les plus fréquentes", "headline": "Flavonols : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Flavonols : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-18", "dateModified": "2025-02-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Flavonols" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Flavonoïdes", "url": "https://questionsmedicales.fr/mesh/D005419", "about": { "@type": "MedicalCondition", "name": "Flavonoïdes", "code": { "@type": "MedicalCode", "code": "D005419", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Kaempférols", "alternateName": "Kaempferols", "url": "https://questionsmedicales.fr/mesh/D044949", "about": { "@type": "MedicalCondition", "name": "Kaempférols", "code": { "@type": "MedicalCode", "code": "D044949", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.388" } } }, { "@type": "MedicalWebPage", "name": "Quercétine", "alternateName": "Quercetin", "url": "https://questionsmedicales.fr/mesh/D011794", "about": { "@type": "MedicalCondition", "name": "Quercétine", "code": { "@type": "MedicalCode", "code": "D011794", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.777" } } }, { "@type": "MedicalWebPage", "name": "Rutoside", "alternateName": "Rutin", "url": "https://questionsmedicales.fr/mesh/D012431", "about": { "@type": "MedicalCondition", "name": "Rutoside", "code": { "@type": "MedicalCode", "code": "D012431", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.888" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "O-(bêta-Hydroxyéthyl)rutosides", "alternateName": "Hydroxyethylrutoside", "url": "https://questionsmedicales.fr/mesh/D006896", "about": { "@type": "MedicalCondition", "name": "O-(bêta-Hydroxyéthyl)rutosides", "code": { "@type": "MedicalCode", "code": "D006896", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.888.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Flavonols", "alternateName": "Flavonols", "code": { "@type": "MedicalCode", "code": "D044948", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Changjie Xu", "url": "https://questionsmedicales.fr/author/Changjie%20Xu", "affiliation": { "@type": "Organization", "name": "Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China." } }, { "@type": "Person", "name": "Kunsong Chen", "url": "https://questionsmedicales.fr/author/Kunsong%20Chen", "affiliation": { "@type": "Organization", "name": "Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China." } }, { "@type": "Person", "name": "Xian Li", "url": "https://questionsmedicales.fr/author/Xian%20Li", "affiliation": { "@type": "Organization", "name": "Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China." } }, { "@type": "Person", "name": "Wei Xue", "url": "https://questionsmedicales.fr/author/Wei%20Xue", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals, Guizhou University, Guiyang, 550025, China. wxue@gzu.edu.cn." } }, { "@type": "Person", "name": "Nguyen Xuan Nhiem", "url": "https://questionsmedicales.fr/author/Nguyen%20Xuan%20Nhiem", "affiliation": { "@type": "Organization", "name": "Institute of Marine Biochemistry, Vietnam Academy of Science and Technology, Hanoi, Vietnam." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study.", "datePublished": "2023-01-20", "url": "https://questionsmedicales.fr/article/36662568", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2196/43122" } }, { "@type": "ScholarlyArticle", "name": "Ability of a Blue Hemoglobin-Based Liquid as a Novel Technology to Stain Initial Enamel Demineralization: A Proof-of-Concept in vitro Study.", "datePublished": "2022-11-30", "url": "https://questionsmedicales.fr/article/36450238", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000528413" } }, { "@type": "ScholarlyArticle", "name": "Global key concepts of civil-military cooperation for disaster management in the COVID-19 pandemic-A qualitative phenomenological scoping review.", "datePublished": "2022-09-15", "url": "https://questionsmedicales.fr/article/36187698", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2022.975667" } }, { "@type": "ScholarlyArticle", "name": "The concept of an agroinfiltration kit for recombinant protein production for educational and commercial use-A journey through a forest of regulatory and legal implications.", "datePublished": "2022-09-05", "url": "https://questionsmedicales.fr/article/36131725", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fbioe.2022.926239" } }, { "@type": "ScholarlyArticle", "name": "A New Alternative Tool to Analyse Glycosylation in Monoclonal Antibodies Based on Drop-Coating Deposition Raman imaging: A Proof of Concept.", "datePublished": "2022-07-09", "url": "https://questionsmedicales.fr/article/35889277", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/molecules27144405" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérobicycliques", "item": "https://questionsmedicales.fr/mesh/D006574" }, { "@type": "ListItem", "position": 5, "name": "Benzopyranes", "item": "https://questionsmedicales.fr/mesh/D001578" }, { "@type": "ListItem", "position": 6, "name": "4H-1-Benzopyran-4-ones", "item": "https://questionsmedicales.fr/mesh/D002867" }, { "@type": "ListItem", "position": 7, "name": "Flavonoïdes", "item": "https://questionsmedicales.fr/mesh/D005419" }, { "@type": "ListItem", "position": 8, "name": "Flavonols", "item": "https://questionsmedicales.fr/mesh/D044948" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Flavonols - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Flavonols", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Flavonols", "description": "Comment détecte-t-on les flavonols dans les aliments ?\nQuels tests mesurent les niveaux de flavonols dans le sang ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Concept+Formation&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Flavonols", "description": "Les flavonols provoquent-ils des symptômes ?\nQuels effets des flavonols sur la santé ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Concept+Formation&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Flavonols", "description": "Comment les flavonols aident-ils à prévenir les maladies ?\nQuels aliments sont riches en flavonols ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Concept+Formation&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Flavonols", "description": "Les flavonols sont-ils utilisés en médecine ?\nComment les flavonols aident-ils dans le traitement du cancer ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Concept+Formation&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Flavonols", "description": "Y a-t-il des complications liées aux flavonols ?\nLes flavonols peuvent-ils causer des effets secondaires ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Concept+Formation&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Flavonols", "description": "Qui devrait éviter les flavonols ?\nLes flavonols sont-ils sûrs pour les femmes enceintes ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Concept+Formation&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on les flavonols dans les aliments ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les flavonols peuvent être détectés par chromatographie et spectrométrie de masse." } }, { "@type": "Question", "name": "Quels tests mesurent les niveaux de flavonols dans le sang ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins spécifiques peuvent quantifier les flavonols et leurs métabolites." } }, { "@type": "Question", "name": "Les flavonols provoquent-ils des symptômes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "En général, les flavonols ne provoquent pas de symptômes, mais des allergies peuvent survenir." } }, { "@type": "Question", "name": "Quels effets des flavonols sur la santé ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les flavonols peuvent réduire l'inflammation et améliorer la santé cardiovasculaire." } }, { "@type": "Question", "name": "Comment les flavonols aident-ils à prévenir les maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils agissent comme antioxydants, réduisant le stress oxydatif et le risque de maladies." } }, { "@type": "Question", "name": "Quels aliments sont riches en flavonols ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les oignons, le thé, les baies et le chocolat noir sont de bonnes sources de flavonols." } }, { "@type": "Question", "name": "Les flavonols sont-ils utilisés en médecine ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les flavonols sont étudiés pour leurs effets bénéfiques sur diverses maladies." } }, { "@type": "Question", "name": "Comment les flavonols aident-ils dans le traitement du cancer ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent inhiber la croissance tumorale et améliorer l'efficacité des traitements." } }, { "@type": "Question", "name": "Y a-t-il des complications liées aux flavonols ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des interactions médicamenteuses peuvent survenir, mais elles sont rares." } }, { "@type": "Question", "name": "Les flavonols peuvent-ils causer des effets secondaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "En général, ils sont sûrs, mais des doses élevées peuvent entraîner des troubles digestifs." } }, { "@type": "Question", "name": "Qui devrait éviter les flavonols ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes allergiques aux flavonoïdes devraient limiter leur consommation de flavonols." } }, { "@type": "Question", "name": "Les flavonols sont-ils sûrs pour les femmes enceintes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "En général, les flavonols sont considérés comme sûrs, mais une consultation médicale est conseillée." } } ] } ] }

Sources (10000 au total)

A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study.

Home-based (unsupervised) buprenorphine initiation is considered safe and effective, yet many patients report barriers to successful treatment initiation. Prescription digital therapeutics (PDTs) are ... The primary objective of this pilot study is to evaluate the acceptability of PEAR-002b in individuals with OUD who use it to support buprenorphine initiation, their unsupervised buprenorphine initiat... Ten adults with OUD will be recruited for acceptability and feasibility testing. Outcomes will be assessed using week-1 visit attendance, participant interviews and satisfaction surveys, and urine dru... This project was funded in September 2019. As of September 2022, participant enrollment is ongoing.... This is the first study to our knowledge to develop a PDT that assists with unsupervised buprenorphine initiation with the intent to better support patients and prescribers during this early phase of ... ClinicalTrials.gov NCT05412966; https://clinicaltrials.gov/ct2/show/NCT05412966.... PRR1-10.2196/43122....

Global key concepts of civil-military cooperation for disaster management in the COVID-19 pandemic-A qualitative phenomenological scoping review.

In the context of a holistic and comprehensive disaster response effort to the COVID-19 pandemic, many countries across the globe mobilized their military forces in order to cope with sudden and expon... The purpose of this work is to identify, map, and render world-wide key concepts of civil-military cooperation (CIMIC) in disaster management during the COVID-19 crisis visible.... Literature was systematically searched in three databases (PubMed, Web of Science, Cochrane Library) on 26 January 2022, and analyzed with qualitative, mixed narrative-phenomenological methods in comp... Forty-five publications were included in the analysis; pertinent authors were from 22 countries covering five continents. We identified three key thematic clusters in the published literature: Cluster... Civil-military cooperation made a significant contribution to the level of resilience in crisis management on a global scale, positively impacting a broad spectrum of core abilities during the COVID-1...

A New Alternative Tool to Analyse Glycosylation in Monoclonal Antibodies Based on Drop-Coating Deposition Raman imaging: A Proof of Concept.

Glycosylation is considered a critical quality attribute of therapeutic proteins as it affects their stability, bioactivity, and safety. Hence, the development of analytical methods able to characteri...

Metagenomic DNA sequencing for semi-quantitative pathogen detection from urine: a prospective, laboratory-based, proof-of-concept study.

Semi-quantitative bacterial culture is the reference standard to diagnose urinary tract infection, but culture is time-consuming and can be unreliable if patients are receiving antibiotics. Metagenomi... In this proof-of-concept study, we prospectively included consecutive urine samples from a clinical diagnostic laboratory in Amsterdam. Urine samples were screened by DNA concentration, followed by PC... We screened 529 urine samples of which 86 were sequenced (43 culture positive and 43 culture negative). The AUROC of the DNA concentration-based screening was 0·85 (95% CI 0·81-0·89). At a cutoff valu... This study provides proof-of-concept of metagenomic semi-quantitative pathogen and resistome detection for the diagnosis of urinary tract infection. The findings warrant prospective clinical validatio... EU Horizon 2020 Research and Innovation Programme....

Unfolding and characterizing the barriers and facilitators of scaling-up evidence-based interventions from the stakeholders' perspective: a concept mapping approach.

Much attention has been paid to scaling-up evidence-based interventions (EBIs) in previous implementation science studies. However, there is limited research on how stakeholders perceive factors of th... This study was conducted using concept mapping. Through purposive sampling, 18 stakeholders were recruited for brainstorming in which they responded to the focus prompt. Here, statements regarding per... Ultimately, 61 statements perceived to influence the scaling-up were grouped into four primary clusters, that is, community-related factors, resource team-related factors, evidence-based practice prog... From the stakeholders' perspective, factors involved in the EBP-PSDIM program scaling-up were initially validated as being multidimensional and conceptually distinct;The importance and feasibility rat...